SPA-10091-HCl
SPA-10091-HCl is a DOT1L degrader that selectively degrades the DOT1L protein via the nuclear ubiquitin-proteasome pathway, thereby inhibiting H3K79 methylation in CRPC cells. It also inhibits DOT1L enzymatic activity (IC50 = 0.87 μM), induces apoptosis, and significantly suppresses tumor growth in vivo.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
27670121 3x 1.0µg DNA
LRRC40 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details MBS2097072-01 0.1 mL
Biotin-Linked Polyclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
Sign In for Pricing
View Details